RESTORE-IT-Study of Rifalazil in Chlamydia Pneumoniae Seropositive Patients With a History of Atherosclerotic Disease

Clinical trial NCT00385385 · UNKNOWN

Trial details

NCT number: NCT00385385
Sponsor: ActivBiotics
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Coronary Artery Disease Cerebrovascular Disease Peripheral Vascular Disease

Start date: 2006-10-01
Enrollment: 72

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.